These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 31588696)

  • 1. Introduction of Vaccinomics to Develop Personalized Vaccines in Light of Changes in the Usage of Hantaan Virus Vaccine (Hantavax®) in Korea.
    Bae JM
    J Prev Med Public Health; 2019 Sep; 52(5):277-280. PubMed ID: 31588696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccinomics, adversomics, and the immune response network theory: individualized vaccinology in the 21st century.
    Poland GA; Kennedy RB; McKinney BA; Ovsyannikova IG; Lambert ND; Jacobson RM; Oberg AL
    Semin Immunol; 2013 Apr; 25(2):89-103. PubMed ID: 23755893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivated Hantaan virus vaccine derived from suspension culture of Vero cells.
    Choi Y; Ahn CJ; Seong KM; Jung MY; Ahn BY
    Vaccine; 2003 May; 21(17-18):1867-73. PubMed ID: 12706671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Phase 1 clinical trial of Hantaan virus and Puumala virus M-segment DNA vaccines for haemorrhagic fever with renal syndrome delivered by intramuscular electroporation.
    Hooper JW; Moon JE; Paolino KM; Newcomer R; McLain DE; Josleyn M; Hannaman D; Schmaljohn C
    Clin Microbiol Infect; 2014 May; 20 Suppl 5():110-7. PubMed ID: 24447183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity and safety of a modified three-dose priming and booster schedule for the Hantaan virus vaccine (Hantavax): A multi-center phase III clinical trial in healthy adults.
    Song JY; Jeong HW; Yun JW; Lee J; Woo HJ; Bae JY; Park MS; Choi WS; Park DW; Noh JY; Cheong HJ; Kim WJ
    Vaccine; 2020 Nov; 38(50):8016-8023. PubMed ID: 33131933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of Hantaan virus RNA from anti-Hantaan virus IgG seronegative rodents in an area of high endemicity in Republic of Korea.
    No JS; Kim WK; Kim JA; Lee SH; Lee SY; Kim JH; Kho JH; Lee D; Song DH; Gu SH; Jeong ST; Kim HC; Klein TA; Song JW
    Microbiol Immunol; 2016 Apr; 60(4):268-71. PubMed ID: 26917012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA vaccination with the Hantaan virus M gene protects Hamsters against three of four HFRS hantaviruses and elicits a high-titer neutralizing antibody response in Rhesus monkeys.
    Hooper JW; Custer DM; Thompson E; Schmaljohn CS
    J Virol; 2001 Sep; 75(18):8469-77. PubMed ID: 11507192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccinomics and a new paradigm for the development of preventive vaccines against viral infections.
    Poland GA; Ovsyannikova IG; Kennedy RB; Haralambieva IH; Jacobson RM
    OMICS; 2011 Sep; 15(9):625-36. PubMed ID: 21732819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The assessment of Hantaan virus-specific antibody responses after the immunization program for hemorrhagic fever with renal syndrome in northwest China.
    Li Z; Zeng H; Wang Y; Zhang Y; Cheng L; Zhang F; Lei Y; Jin B; Ma Y; Chen L
    Hum Vaccin Immunother; 2017 Apr; 13(4):802-807. PubMed ID: 27824286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hantaan virus surveillance targeting small mammals at nightmare range, a high elevation military training area, Gyeonggi Province, Republic of Korea.
    Klein TA; Kim HC; Chong ST; Kim JA; Lee SY; Kim WK; Nunn PV; Song JW
    PLoS One; 2015; 10(4):e0118483. PubMed ID: 25874643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary humoral immune responses to formalin inactivated hemorrhagic fever with renal syndrome vaccine (Hantavax): consideration of active immunization in South Korea.
    Sohn YM; Rho HO; Park MS; Kim JS; Summers PL
    Yonsei Med J; 2001 Jun; 42(3):278-84. PubMed ID: 11456392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Personalized vaccinology: A review.
    Poland GA; Ovsyannikova IG; Kennedy RB
    Vaccine; 2018 Aug; 36(36):5350-5357. PubMed ID: 28774561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incorporation of GM-CSF or CD40L Enhances the Immunogenicity of Hantaan Virus-Like Particles.
    Cheng LF; Wang F; Zhang L; Yu L; Ye W; Liu ZY; Ying QK; Wu XA; Xu ZK; Zhang FL
    Front Cell Infect Microbiol; 2016; 6():185. PubMed ID: 28066721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction and immunological characterization of CD40L or GM-CSF incorporated Hantaan virus like particle.
    Ying Q; Ma T; Cheng L; Zhang X; Truax AD; Ma R; Liu Z; Lei Y; Zhang L; Ye W; Zhang F; Xu Z; Shang L; Liu R; Wang F; Wu X
    Oncotarget; 2016 Sep; 7(39):63488-63503. PubMed ID: 27542281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Phase 1 clinical trial of Hantaan virus and Puumala virus M-segment DNA vaccines for hemorrhagic fever with renal syndrome.
    Boudreau EF; Josleyn M; Ullman D; Fisher D; Dalrymple L; Sellers-Myers K; Loudon P; Rusnak J; Rivard R; Schmaljohn C; Hooper JW
    Vaccine; 2012 Mar; 30(11):1951-8. PubMed ID: 22248821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hantaan virus surveillance in small mammals at firing points 10 and 60, Yeoncheon, Gyeonggi Province, Republic of Korea.
    Klein TA; Kim HC; Chong ST; O'Guinn ML; Lee JS; Turell MJ; Sames WJ; Gu SH; Kang HJ; Moon S; Lee SY; Chun Y; Song JW
    Vector Borne Zoonotic Dis; 2012 Aug; 12(8):674-82. PubMed ID: 22607077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequence-Independent, Single-Primer Amplification Next-Generation Sequencing of Hantaan Virus Cell Culture-Based Isolates.
    Song DH; Kim WK; Gu SH; Lee D; Kim JA; No JS; Lee SH; Wiley MR; Palacios G; Song JW; Jeong ST
    Am J Trop Med Hyg; 2017 Feb; 96(2):389-394. PubMed ID: 27895275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic Diversity and Reassortment of Hantaan Virus Tripartite RNA Genomes in Nature, the Republic of Korea.
    Kim JA; Kim WK; No JS; Lee SH; Lee SY; Kim JH; Kho JH; Lee D; Song DH; Gu SH; Jeong ST; Park MS; Kim HC; Klein TA; Song JW
    PLoS Negl Trop Dis; 2016 Jun; 10(6):e0004650. PubMed ID: 27315053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incorporation of CD40 ligand or granulocyte-macrophage colony stimulating factor into Hantaan virus (HTNV) virus-like particles significantly enhances the long-term immunity potency against HTNV infection.
    Dong Y; Ma T; Zhang X; Ying Q; Han M; Zhang M; Yang R; Li Y; Wang F; Liu R; Wu X
    J Med Microbiol; 2019 Mar; 68(3):480-492. PubMed ID: 30657443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Systems Vaccinology Approach Reveals the Mechanisms of Immunogenic Responses to Hantavax Vaccination in Humans.
    Khan A; Shin OS; Na J; Kim JK; Seong RK; Park MS; Noh JY; Song JY; Cheong HJ; Park YH; Kim WJ
    Sci Rep; 2019 Mar; 9(1):4760. PubMed ID: 30886186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.